Preoperative Intravitreal Ranibizumab for Persistent Diabetic Vitreous Haemorrhage:

NCT01030770 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Complications

Interventions

DRUG: Ranibizumab
DRUG: 0.9% Sodium Chloride

Sponsor

King's College Hospital NHS Trust

Collaborators

[object Object]